We are live on ! Find out more

Small Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
CNMD icon
51
CONMED
CNMD
$1.49B
$1.49B $49.65 1.51%
HCSG icon
52
Healthcare Services Group
HCSG
$1.48B
$1.48B $21.55 0.19%
ATEC icon
53
Alphatec Holdings
ATEC
$1.46B
$1.46B $9.46 3.37%
ENOV icon
54
Enovis
ENOV
$1.45B
$1.45B $25.17 3.42%
AZTA icon
55
Azenta
AZTA
$1.45B
$1.45B $33.03 1.05%
OMDA
56
Omada Health Inc
OMDA
$1.45B
$1.45B $23.86 0.75%
AVBP icon
57
ArriVent BioPharma
AVBP
$1.44B
$1.44B $29.27 0.81%
INNV icon
58
InnovAge Holding
INNV
$1.44B
$1.44B $10.60 0.09%
MLTX icon
59
MoonLake Immunotherapeutics
MLTX
$1.41B
$1.41B $16.60 0.79%
AORT icon
60
Artivion
AORT
$1.39B
$1.39B $28.61 1.82%
PAHC icon
61
Phibro Animal Health
PAHC
$1.39B
$1.39B $34.21 0.44%
IART icon
62
Integra LifeSciences
IART
$1.39B
$1.39B $17.84 2.73%
ORIC icon
63
Oric Pharmaceuticals
ORIC
$1.39B
$1.39B $13.37 3.6%
AKTS
64
Aktis Oncology
AKTS
$1.37B
$1.37B $24.61 1.28%
VOR icon
65
Vor Biopharma
VOR
$1.35B
$1.35B $22.86 0.74%
PNTG icon
66
Pennant Group
PNTG
$1.35B
$1.35B $38.69 1.6%
CGEM icon
67
Cullinan Oncology
CGEM
$1.34B
$1.34B $20.85 2.51%
REPL icon
68
Replimune Group
REPL
$1.34B
$1.34B $14.31 4.41%
FRNM
69
Freenome Inc
FRNM
$1.34B
$1.34B $12.60 9%
NVAX icon
70
Novavax
NVAX
$1.33B
$1.33B $8.09 0.5%
APMD
71
Apnimed Inc
APMD
$1.33B
$1.33B $33.50 5.51%
DRTS icon
72
Alpha Tau Medical
DRTS
$1.33B
$1.33B $14.40 1.05%
AMN icon
73
AMN Healthcare
AMN
$1.33B
$1.33B $34.36 0.41%
INBX icon
74
Inhibrx
INBX
$1.33B
$1.33B $90.31 2.2%
GLUE icon
75
Monte Rosa Therapeutics
GLUE
$1.33B
$1.33B $15.55 0.32%

Small Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 321 small cap Healthcare stocks — companies in the Healthcare sector with a market cap between $250M and $2B — worth a combined $276B.

The largest by market cap are Taysha Gene Therapies (TSHA) at $2B, Zenas BioPharma (ZBIO) at $1.96B and Progyny (PGNY) at $1.95B.

Among institutional investors, First Tracks Biotherapeutics (TRAX) drew the most net new fund positions in Q2 2026: 148 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.